{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T21:43:14Z","timestamp":1696628594670},"reference-count":29,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2015,6,4]],"date-time":"2015-06-04T00:00:00Z","timestamp":1433376000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2015,6,4]],"date-time":"2015-06-04T00:00:00Z","timestamp":1433376000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidemiol Drug Saf"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1002\/pds.3802","type":"journal-article","created":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T03:06:44Z","timestamp":1433473604000},"page":"803-811","source":"Crossref","is-referenced-by-count":1,"title":["Effects of expiring reimbursability of pentaerythrityl tetranitrate (PETN, pentalong\u00ae) on anti-anginal therapy: an observational study"],"prefix":"10.1002","volume":"24","author":[{"given":"Thomas","family":"Grimmsmann","sequence":"first","affiliation":[{"name":"Health Insurance Medical Service (MDK) Mecklenburg-Vorpommern; Schwerin Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Chenot","sequence":"additional","affiliation":[{"name":"Department of General Practice, Institute for Community Medicine; University Medicine Greifswald; Greifswald Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aniela","family":"Angelow","sequence":"additional","affiliation":[{"name":"Department of General Practice, Institute for Community Medicine; University Medicine Greifswald; Greifswald Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,6,4]]},"reference":[{"issue":"25","key":"10.1002\/pds.3802-BIB0001|pds3802-cit-0001","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1161\/CIR.0b013e3182776f83","article-title":"2012 ACCF\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary","volume":"126","author":"Fihn","year":"2012","journal-title":"Circulation"},{"key":"10.1002\/pds.3802-BIB0002|pds3802-cit-0002","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1001\/jama.281.20.1927","article-title":"Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina","volume":"281","author":"Heidenreich","year":"1999","journal-title":"JAMA"},{"key":"10.1002\/pds.3802-BIB0003|pds3802-cit-0003","unstructured":"Programm f\u00fcr Nationale VersorgungsLeitlinien Nationale VersorgungsLeitlinie chronische KHK. Langfassung. 3. Auflage. Version 1 2014 http:\/\/www.leitlinien.de\/mdb\/downloads\/nvl\/khk\/khk-3aufl-vers1-lang.pdf"},{"key":"10.1002\/pds.3802-BIB0004|pds3802-cit-0004","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0002-9149(82)90518-5","article-title":"Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy","volume":"49","author":"Thadani","year":"1982","journal-title":"Am J Cardiol"},{"issue":"38","key":"10.1002\/pds.3802-BIB0005|pds3802-cit-0005","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease","volume":"34","author":"Task Force on the management of stable coronary artery disease of the European Society of Cardiology","year":"2013","journal-title":"Eur Heart J"},{"issue":"S1","key":"10.1002\/pds.3802-BIB0006|pds3802-cit-0006","doi-asserted-by":"crossref","first-page":"25S","DOI":"10.1111\/j.1365-2125.1992.tb04145.x","article-title":"Effects of nitrates on mortality in acute myocardial infarction and in heart failure","volume":"34","author":"Held","year":"1992","journal-title":"Br J Clin Pharmacol"},{"key":"10.1002\/pds.3802-BIB0007|pds3802-cit-0007","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/heartjnl-2011-301436","article-title":"Management of stable angina: summary of NICE guidance","volume":"98","author":"Henderson","year":"2012","journal-title":"Heart"},{"issue":"8","key":"10.1002\/pds.3802-BIB0008|pds3802-cit-0008","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJM199802193380807","article-title":"Nitrate therapy for stable angina pectoris","volume":"338","author":"Parker","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1002\/pds.3802-BIB0009|pds3802-cit-0009","first-page":"183","article-title":"Nitrate therapy for heart failure. Benefits and strategies to overcome tolerance","volume":"1","author":"Gupta","year":"2013","journal-title":"J Am Coll Cardiol HF"},{"key":"10.1002\/pds.3802-BIB0010|pds3802-cit-0010","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/978-3-642-21992-4","volume-title":"Arzneiverordnungs-Report 2011","author":"Schwabe","year":"2011"},{"issue":"14","key":"10.1002\/pds.3802-BIB0011|pds3802-cit-0011","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/eurheartj\/eht384","article-title":"Efficacy of the long-acting nitro vasodilator pentaerythrityl tetranitrate in patients with chronic stable angina pectoris receiving anti-anginal background therapy with beta-blockers: a 12-week, randomized, double-blind, placebo-controlled trial","volume":"35","author":"M\u00fcnzel","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1002\/pds.3802-BIB0012|pds3802-cit-0012","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/978-3-642-29242-2","volume-title":"Arzneiverordnungs-Report 2012","author":"Schwabe","year":"2012"},{"key":"10.1002\/pds.3802-BIB0013|pds3802-cit-0013","unstructured":"Neubauer K. 50 Jahre altes Herzmittel: \u00c4rzte streiten mit Beh\u00f6rden \u00fcber Zulassung f\u00fcr Pentalong 2013 http:\/\/www.spiegel.de\/gesundheit\/diagnose\/pentalong-streit-um-zulassung-fuer-50-jahre-altes-herzmittel-a-915457.html"},{"key":"10.1002\/pds.3802-BIB0014|pds3802-cit-0014","first-page":"19","article-title":"Warum\u2026Warum\u2026Warum","volume":"4","author":"Schuett","year":"2012","journal-title":"KV J Mecklenburg-Vorpommern"},{"key":"10.1002\/pds.3802-BIB0015|pds3802-cit-0015","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/978-3-642-37124-0","volume-title":"Arzneiverordnungs-Report 2013","author":"Schwabe","year":"2013"},{"key":"10.1002\/pds.3802-BIB0016|pds3802-cit-0016","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0891-5849(99)00066-0","article-title":"Comparison of glyceryl trinitrate-induced with pentaerythrityl tetranitrate-induced in vivo formation of superoxide radicals: effect of vitamin C","volume":"27","author":"Dikalov","year":"1999","journal-title":"Free Radic Biol Med"},{"key":"10.1002\/pds.3802-BIB0017|pds3802-cit-0017","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0735-1097(01)01414-0","article-title":"Differential effects of pentaerythritol tetranitrate and nitroglycerin on the development of tolerance and evidence of lipid peroxidation: a human in vivo study","volume":"38","author":"Gori","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1002\/pds.3802-BIB0018|pds3802-cit-0018","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/S0002-9149(03)00342-4","article-title":"Comparison of the effects of pentaerythritol tetranitrate and nitroglycerin on endothelium-dependent vasorelaxation in male volunteers","volume":"91","author":"Gori","year":"2003","journal-title":"Am J Card"},{"key":"10.1002\/pds.3802-BIB0019|pds3802-cit-0019","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00392-007-0588-7","article-title":"New insights into bioactivation of organic nitrates, nitrate tolerance and cross-tolerance","volume":"97","author":"Daiber","year":"2008","journal-title":"Clin Res Cardiol"},{"key":"10.1002\/pds.3802-BIB0020|pds3802-cit-0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00392-009-0096-z","article-title":"Effects of pentaerythritol tetranitrate on endothelial function in coronary artery disease: results of the PENTA study","volume":"99","author":"Schnorbus","year":"2010","journal-title":"Clin Res Cardiol"},{"issue":"18","key":"10.1002\/pds.3802-BIB0021|pds3802-cit-0021","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1001\/archinternmed.2010.355","article-title":"Feasibility study of a systematic approach for discontinuation of multiple medications in older adults. Addressing polypharmacy","volume":"170","author":"Garfinkel","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1002\/pds.3802-BIB0022|pds3802-cit-0022","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/S0012-3692(15)33392-4","article-title":"Safety of nitrate withdrawal in angina-free and hemodynamically stable patients with coronary artery disease","volume":"124","author":"George","year":"2003","journal-title":"Chest"},{"key":"10.1002\/pds.3802-BIB0023|pds3802-cit-0023","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/MCA.0000000000000083","article-title":"Effect of nitrate withdrawal on quality of life and adherence to treatment in patients with stable angina: evidence from a randomized clinical trial","volume":"25","author":"Lemosa","year":"2014","journal-title":"Coron Artery Dis"},{"key":"10.1002\/pds.3802-BIB0024|pds3802-cit-0024","unstructured":"Programm f\u00fcr Nationale VersorgungsLeitlinien Nationale VersorgungsLeitlinie Chronische KHK. Langfassung. 1. Auflage. Version 1.13 2006 http:\/\/www.leitlinien.de\/nvl\/khk\/archiv"},{"issue":"3","key":"10.1002\/pds.3802-BIB0025|pds3802-cit-0025","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/clpt.2011.250","article-title":"Effect of the market withdrawal of carisoprodol on use of other prescribed drugs with abuse potential","volume":"91","author":"Bramness","year":"2012","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"10.1002\/pds.3802-BIB0026|pds3802-cit-0026","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/pds.1451","article-title":"What happened to the prescribing of other COX-2 inhibitors, paracetamol and non-steroidal anti-inflammatory drugs when rofecoxib was withdrawn in Australia?","volume":"16","author":"Barozzi","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1002\/pds.3802-BIB0027|pds3802-cit-0027","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/jama.1990.03440060077036","article-title":"Withdrawing payment for nonscientific drug therapy. Intended and unexpected effects of a large-scale natural experiment","volume":"263","author":"Soumerai","year":"1990","journal-title":"JAMA"},{"issue":"50","key":"10.1002\/pds.3802-BIB0028|pds3802-cit-0028","first-page":"856","article-title":"Prescription prevalence and continuing medication use for secondary prevention after myocardial infarction: the reality of care revealed by claims data analysis","volume":"108","author":"Mangiapane","year":"2011","journal-title":"Dtsch Arztebl Int"},{"key":"10.1002\/pds.3802-BIB0029|pds3802-cit-0029","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1055\/s-2004-820384","article-title":"Auswirkungen des GMG(GKV-Modernisierungs-Gesetz) auf hausaerztliche Verordnungen am Beispiel des akuten Hustens","volume":"80","author":"Altiner","year":"2004","journal-title":"Z Allg Med"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3802","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3802","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/pds.3802\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T05:01:01Z","timestamp":1652245261000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.3802"}},"subtitle":["Effects of Expiring PETN Reimbursability"],"short-title":[],"issued":{"date-parts":[[2015,6,4]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"URL":"https:\/\/doi.org\/10.1002\/pds.3802","archive":["Portico"],"relation":{},"ISSN":["1053-8569"],"issn-type":[{"value":"1053-8569","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6,4]]}}}